project id: TCGA-STAD; case submitter id: TCGA-FP-A8CX; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.91; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.72; rna integrity number: 7.8; age at index: 60; days to birth: -22000; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1953; age at diagnosis: 22000; ajcc pathologic m: MX; ajcc pathologic n: N3a; ajcc pathologic stage: Stage IIIC; ajcc pathologic t: T4b; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 7.0; icd 10 code: C16.2; last known disease status: not reported; morphology: 8490/3; primary diagnosis: Signet ring cell carcinoma; prior malignancy: yes; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Body of stomach; synchronous malignancy: No; tissue or organ of origin: Body of stomach; tumor grade: Not Reported; year of diagnosis: 2013; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 56; days to sample procurement: 0; initial weight: 40.0; portion submitter id: TCGA-FP-A8CX-01A-11; percent lymphocyte infiltration: 40.0; percent monocyte infiltration: 20.0; percent necrosis: 0.0; percent neutrophil infiltration: 20.0; percent normal cells: 10.0; percent stromal cells: 20.0; percent tumor cells: 70.0; percent tumor nuclei: 70.0;